TheJobsMapCellCentric jobs and careers
About CellCentric
CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
Founded in 2003 by Will West.
- Founded
- 2003
- Employees
- 11 to 50
- Total funding
- $135.6M
Leadership
The top of CellCentric's org chart, with how many people report into each leader.
Debbie Haynes
Chief Operating Officer
15 reports
Karen Clegg
Clinical Science Director
8 reports
Jeff Barrus
Vice President, Regulatory Affairs & Quality Assurance
3 reports
Sofia Paul
Vp, Head Of Stats, Programming And DM
1 report
Jobs at CellCentric
No open positions right now. Explore more companies on TheJobsMap.